Socius firmus - Company finances
|
EUR
|
2022
From: 2022-05-20
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 2,000 | 2,500 | 2,080 |
| Profit before tax | -1,013 | -1,317 | -1,149 | -1,602 |
| Net profit | -1,013 | -1,317 | -1,149 | -1,602 |
| Equity | 6,447,987 | 6,446,670 | 6,445,521 | 6,443,919 |
| Liabilities | 201 | 534 | 1,487 | 1,502,589 |
| Non-current assets | 6,446,360 | 5,490,360 | 5,490,360 | 5,490,360 |
| Current assets | 1,828 | 956,844 | 956,648 | 2,456,148 |
| Total assets | 6,448,188 | 6,447,204 | 6,447,008 | 7,946,508 |
|
Taxes paid
|
||||
| STI taxes | - | 428 | 429 | 312 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +25.0% | -16.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 0.0% | 0.0% | 0.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -65.9% | -46.0% | -77.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -65.9% | -46.0% | -77.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 1,600 | 1,250 | 1,040 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Socius firmus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-08-06 | 25.78 |
| 2026-07-16 | 2026-07-17 | 25.78 |
| 2026-03-27 | 2026-03-27 | 25.98 |
| 2026-03-17 | 2026-03-25 | 25.98 |
| 2025-11-21 | 2025-12-14 | 0.24 |
| 2025-11-18 | 2025-11-20 | 46.97 |
| 2025-10-23 | 2025-11-17 | 0.24 |
| 2025-09-16 | 2025-09-24 | 48.31 |
| 2025-09-07 | 2025-09-15 | 1.58 |
| 2025-08-31 | 2025-09-03 | 1.58 |
| 2025-08-28 | 2025-08-29 | 48.31 |
| 2025-08-25 | 2025-08-27 | 1.58 |
| 2025-08-19 | 2025-08-24 | 48.31 |
| 2025-07-24 | 2025-08-18 | 1.58 |
| 2025-07-17 | 2025-07-23 | 1.45 |
| 2025-07-16 | 2025-07-16 | 48.18 |
| 2025-06-26 | 2025-07-15 | 1.45 |
| 2025-06-17 | 2025-06-25 | 48.18 |
| 2025-06-11 | 2025-06-16 | 1.45 |
| 2025-06-08 | 2025-06-09 | 1.45 |
| 2025-05-16 | 2025-06-04 | 1.45 |
| 2025-05-04 | 2025-05-11 | 1.45 |
| 2025-04-30 | 2025-04-30 | 1.07 |
| 2025-04-24 | 2025-04-29 | 1.45 |
| 2025-04-16 | 2025-04-23 | 1.07 |
| 2025-03-18 | 2025-04-14 | 1.07 |
| 2025-02-18 | 2025-03-13 | 47.80 |
| 2025-01-20 | 2025-02-17 | 1.07 |
| 2025-01-16 | 2025-01-19 | 47.80 |
| 2025-01-02 | 2025-01-15 | 1.07 |
| 2024-12-22 | 2024-12-31 | 1.07 |
| 2024-12-17 | 2024-12-20 | 1.07 |
| 2024-11-18 | 2024-12-11 | 1.07 |
| 2024-10-24 | 2024-11-14 | 1.07 |
| 2024-09-26 | 2024-09-30 | 9.75 |
| 2024-09-18 | 2024-09-25 | 47.13 |
| 2024-09-17 | 2024-09-17 | 93.86 |
| 2024-07-24 | 2024-09-16 | 47.13 |
| 2024-07-16 | 2024-07-23 | 46.72 |
| 2024-06-18 | 2024-07-14 | 46.72 |
| 2024-05-16 | 2024-05-16 | 46.72 |
Socius firmus - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Socius firmus, UAB (code 306075055) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €2.1K, down from €2.5K in 2024 but slightly above €2.0K in 2023. This means revenue declined by 16.8% year on year, while the two-year change was +4.0%. The business remained loss-making, with a net loss of €1.6K in 2025, compared with losses of €1.1K in 2024 and €1.3K in 2023. Given the very small revenue base, profitability remained weak and margin pressure increased in 2025. Total assets rose to €7.95M in 2025 from €6.45M in both 2023 and 2024. Equity was broadly stable at €6.44M, while liabilities increased to €1.50M from €1.5K in 2024. The balance sheet remained strongly equity-financed, with an equity ratio of 81.1% and debt-to-equity of 0.23. Revenue per employee was €1.0K and profit per employee was -€801.